Share your story

QOL Medical is interested to hear from those who have Congenital Sucrase-Isomaltase Deficiency (CSID), or their caregivers regarding their experience with Sucraid®. Please use the form below to share your story.

Patient testimonial form

The staff at QOL Medical like to hear from affected individuals, parents, and caregivers about their experiences with Sucraid® for the treatment of Congenital Sucrase-Isomaltase Deficiency (CSID). If you are interested in sharing your experience and stories, we welcome you to do so.

By submitting your information or your child’s information, you agree that it will be governed by the Consent and Release statement below.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Consent and Release

I hereby grant QOL Medical the maker of Sucraid® permission to use my or my child’s first name and last initial, their state of residence, and patient testimonial (which may include some or all of the information inserted above) on www.sucraid.com. By signing this form, you are hereby consenting on your behalf and that of your child to allow QOL Medical to use and disclose the information in your or your child’s testimonial and acknowledge that your or your child’s testimonial may be distributed to the public. You or your child have the right to revoke this Consent and Release at any time by providing your written notice of your revocation and submitting it to the Contact Person listed below. Please understand that revocation of this Release will not affect any action QOL Medical took in reliance on this Release before receiving your or your child’s revocation.

I hereby authorize QOL Medical and staff to use my or my child’s testimonial and any information contained herein in its patient assistance or patient education programs, on its websites, and in its public relations or other business efforts. I understand and approve the disclosure of my or my child’s testimonial information on its websites or other media and other individuals and entities that may be involved in the business, healthcare, or public relations efforts of QOL Medical.

QOL Medical may at its/their sole discretion make any and all changes in, additions to, and deletions from the testimonial including without limitation, cuts, edits, additions, changes, rearrangement, adaptation of the information to different formats, and other changes, additions, and deletions necessary to make the testimonial usable by QOL Medical. I understand and agree that the provided information may be used on, in, or in connection with any published materials and may be used, amended, transferred, displayed, broadcast, reproduced, and/or distributed publicly or otherwise, for any purposes whatsoever, including, but not limited to, educational, promotional, or commercial purposes.

I also release QOL Medical for any use of the provided information by third parties who intercept the materials or gain access to them over the Internet or other electronic media without QOL Medical’s permission, and for any claim of alteration, optical illusion, or faulty mechanical reproduction, distortion, or illusion in reproduction. I understand that this Consent and Release does not obligate QOL Medical to use the provided information on or in connection with any materials.

I waive the right of prior approval and hereby release and hold harmless QOL Medical and its staff from any and all claims for damages of any kind based on the use of my or my child’s testimonial or information in the testimonial or by virtue of this authorization. By signing below, I agree and acknowledge that I have read and understood the above Consent and Release and agree to all terms described. I am of legal age, have read this Consent and Release, and freely sign this Consent and Release of my or my child’s testimonial.



Agree*
Important Safety Information
Sucraid® (sacrosidase) Oral Solution
  • Do not prescribe Sucraid® to patients known to be hypersensitive to yeast, yeast products, papain, or glycerin (glycerol).
  • Sucraid® may cause a serious allergic reaction. Patients should stop taking Sucraid® and get emergency help immediately if any of the following side effects occur: difficulty breathing, wheezing, or swelling of the face. Care should be taken when administering initial doses of Sucraid® to observe any signs of acute hypersensitivity reaction.
  • Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.
  • Adverse reactions as a result of taking Sucraid® may include worse abdominal pain, vomiting, nausea, diarrhea, constipation, difficulty sleeping, headache, nervousness, and dehydration.
  • Before prescribing Sucraid® to diabetic patients, the physician should consider that Sucraid® will enable sucrose hydrolysis and the absorption of those hydrolysis products, glucose and fructose.
  • The effects of Sucraid® have not been evaluated in patients with secondary (acquired) disaccharidase deficiency.
  • DO NOT HEAT SOLUTIONS CONTAINING SUCRAID®. Do not put Sucraid® in warm or hot fluids. Do not reconstitute or consume Sucraid® with fruit juice since the acidity of the juice may reduce the enzyme activity of Sucraid®. Half of the reconstituted Sucraid® should be taken at the beginning of the meal or snack and the other half during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light; single-use containers can be removed from refrigeration and stored at 59°F-77°F (15°C-25°C) for up to 3 days (72 hours). Refer to Instructions for Use for full information on how to take Sucraid®.
Indication
Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.

IMPORTANT SAFETY INFORMATION:

Important Safety Information for Sucraid® (sacrosidase) Oral Solution

  • Do not prescribe Sucraid® to patients known to be hypersensitive to yeast, yeast products, papain, or glycerin (glycerol).
  • Sucraid® may cause a serious allergic reaction. Patients should stop taking Sucraid® and get emergency help immediately if any of the following side effects occur: difficulty breathing, wheezing, or swelling of the face. Care should be taken when administering initial doses of Sucraid® to observe any signs of acute hypersensitivity reaction.
  • Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.
  • Adverse reactions as a result of taking Sucraid® may include worse abdominal pain, vomiting, nausea, diarrhea, constipation, difficulty sleeping, headache, nervousness, and dehydration.
  • Before prescribing Sucraid® to diabetic patients, the physician should consider that Sucraid® will enable sucrose hydrolysis and the absorption of those hydrolysis products, glucose and fructose.
  • The effects of Sucraid® have not been evaluated in patients with secondary (acquired) disaccharidase deficiency.
  • DO NOT HEAT SOLUTIONS CONTAINING SUCRAID®. Do not put Sucraid® in warm or hot fluids. Do not reconstitute or consume Sucraid® with fruit juice since the acidity of the juice may reduce the enzyme activity of Sucraid®. Half of the reconstituted Sucraid® should be taken at the beginning of the meal or snack and the other half during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light; single-use containers can be removed from refrigeration and stored at 59°F-77°F (15°C-25°C) for up to 3 days (72 hours). Refer to Instructions for Use for full information on how to take Sucraid®.

Indication

Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.